Evaluation of WLBU2 Peptide and 3- O -Octyl- sn -Glycerol Lipid as Active Ingredients for a Topical Microbicide Formulation Targeting Chlamydia trachomatis
Authors:
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (2) , 627-636
Abstract
Topical microbicides for prevention of sexually transmitted diseases (STDs) would be especially useful for women who are not able to persuade their partner(s) to take precautions. Many topical microbicides are in various stages of development, based on a variety of active ingredients. We investigated the in vitro activity of an engineered antimicrobial peptide (WLBU2) and a lipid (3- O -octyl- sn -glycerol [3-OG]) which could potentially be used as active ingredients in such a product. Using commercially available cytotoxicity reagents [Alamar Blue, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), and lactate dehydrogenase (LDH)], we first determined the toxicity of WLBU2 and 3-OG to the host cells in our assay procedure and excluded toxic concentrations from further testing. To determine activity against Chlamydia trachomatis , we used an assay previously developed by our laboratory in which chlamydial elementary bodies (EBs) were exposed to microbicides prior to contact with epithelial cells: the minimum (microbi)cidal concentration (MCC) assay. To further simulate conditions of transmission, we carried out the same assay in the presence of a simulated vaginal fluid, a simulated seminal fluid, human serum albumin, and a range of pH values which might be found in the human vagina at the time of exposure. Last, we tested WLBU2 and 3-OG in combination to determine if adding them together resulted in synergistic activity. We found that WLBU2 and 3-OG both have excellent activity in vitro against C. trachomatis and significantly more activity when added together. The simulated fluids reduced activity, but the synergy seen is good evidence that they would be effective when combined in a microbicide formulation.Keywords
This publication has 49 references indexed in Scilit:
- Glycerol monolaurate prevents mucosal SIV transmissionNature, 2009
- Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase InhibitorAntimicrobial Agents and Chemotherapy, 2009
- Glycerol Monolaurate Does Not Alter Rhesus Macaque ( Macaca mulatta ) Vaginal Lactobacilli and Is Safe for Chronic UseAntimicrobial Agents and Chemotherapy, 2008
- Short Communication: Enhancement of HIV Infection by Cellulose SulfateAIDS Research and Human Retroviruses, 2008
- Inhibitory Effect of PRO 2000, a Candidate Microbicide, on Dendritic Cell-Mediated Human Immunodeficiency Virus TransferAntimicrobial Agents and Chemotherapy, 2008
- Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (Group B Streptococcus), Haemophilus ducreyi , and Vaginal Lactobacillus by 3- O -Octyl- sn -GlycerolAntimicrobial Agents and Chemotherapy, 2008
- De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemiaJournal of Antimicrobial Chemotherapy, 2007
- Efficacy of the De Novo-Derived Antimicrobial Peptide WLBU2 against Oral BacteriaAntimicrobial Agents and Chemotherapy, 2007
- Carrageenan Is a Potent Inhibitor of Papillomavirus InfectionPLOS Pathogens, 2006
- A Review of the Physical and Chemical Properties of Human Semen and the Formulation of a Semen SimulantJournal of Andrology, 2005